Europe Heart Valve Devices Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2024 –2030 |
 حجم السوق (السنة الأساسية) |
|
 حجم السوق (سنة التنبؤ) |
USD 6,980.37 |
 CAGR |
% |
| Major Markets Players |
سوق أجهزة صمامات القلب في أوروبا، حسب نوع المنتج ( صمامات القلب الميكانيكية وصمامات القلب البيولوجية وصمامات القسطرة)، العلاج ( الجراحة المفتوحة والجراحة الأقل توغلاً (MIS))، المستخدم النهائي (المستشفيات والعيادات ومراكز الجراحة الخارجية ومراكز القلب ومراكز الأبحاث وغيرها)، قناة التوزيع (العطاء المباشر والموزعون الخارجيون)، اتجاهات الصناعة والتوقعات حتى عام 2030.
تحليل ورؤى حول سوق أجهزة صمامات القلب في أوروبا
تُستخدم أجهزة صمام القلب لعلاج صمامات القلب المسدودة، وزرع هذه الأجهزة هو أحد الإجراءات الأكثر شيوعًا. تشمل أجهزة صمام القلب البنيوية المتاحة في السوق الصمامات الميكانيكية والبيولوجية والقسطرة. من المرجح أن ينمو سوق أجهزة صمام القلب في أوروبا بشكل مطرد خلال فترة التنبؤ بسبب العدد المتزايد من جراحات صمام القلب في جميع أنحاء العالم. من المتوقع أن يكون نمو سوق أجهزة صمام القلب في أوروبا مدفوعًا بالتطورات في أجهزة القلب البنيوية والإجراءات مثل صمامات الأبهر وأجهزة انسداد الأذين الأيسر وصمامات الأنسجة أو البيولوجية. لقد أحدثت صمامات الأنسجة ثورة في سوق أجهزة صمام القلب. تقدم جراحات صمام القلب من الجيل التالي ملفات تعريف منخفضة للمرضى، وجراحات أكثر تحكمًا، ووظيفة صمام أفضل، وارتجاع صمامي أقل، ومتانة متزايدة، وتكاليف أقل. عززت ابتكارات المنتجات من قبل اللاعبين الرئيسيين في السوق نمو السوق من خلال تمكينهم من معالجة عدد أكبر من المرضى وتحقيق نتائج سريرية أفضل.
تحلل شركة Data Bridge Market Research أن سوق أجهزة صمامات القلب في أوروبا من المتوقع أن تصل قيمته إلى 6,980.37 مليون دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب قدره 12.8% خلال الفترة المتوقعة. يشكل نوع المنتج أكبر شريحة من الأنواع في السوق بسبب الطلب السريع على أجهزة صمامات القلب على مستوى العالم. يغطي تقرير السوق هذا أيضًا تحليل الأسعار وتحليل براءات الاختراع والتقدم التكنولوجي بعمق.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2023 إلى 2030 |
|
سنة الأساس |
2022 |
|
سنوات تاريخية |
2021 (قابلة للتخصيص حتى 2020 - 2015) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية، الأحجام بالوحدات، التسعير بالدولار الأمريكي |
|
القطاعات المغطاة |
حسب نوع المنتج (صمامات القلب الميكانيكية وصمامات القلب البيولوجية وصمامات القسطرة)، العلاج (الجراحة المفتوحة والجراحة قليلة التوغل (MIS))، المستخدم النهائي (المستشفيات والعيادات ومراكز الجراحة الخارجية ومراكز القلب ومراكز الأبحاث وغيرها)، قناة التوزيع (العطاء المباشر، الموزعون التابعون لجهات خارجية). |
|
الدول المغطاة |
ألمانيا، فرنسا، المملكة المتحدة، إيطاليا، روسيا، إسبانيا، هولندا، سويسرا، النرويج، بولندا، السويد، بلجيكا، تركيا، الدنمارك، فنلندا وبقية أوروبا. |
|
الجهات الفاعلة في السوق المشمولة |
Abbott, Boston Scientific Corporation or its affiliates, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve among others. |
Heart Valve Devices Market Definition
Heart valves are necessary to smooth blood movement in the right direction in the body. Heart valves are responsible for constant blood flow, and maintaining blood pressure. If they don't work properly cutting off the heart causes stenosis. Heart disease generally includes several diseases that significantly affect the heart. The regulation of heart valves has increased rapidly in the last ten years as the number of patients suffering from cardiovascular diseases has increased. The market growth of heart valves is accelerated by factors such as unstable lifestyles, lifestyle diseases, increasing smoking population, aging population, and increasing quality of healthcare, and rapid development of healthcare reimbursement during the forecast period. In addition, the high cost of heart valves and the risk of infection of heart implants may be the reason that is likely to slow down the growth of the heart valve market during the above-mentioned forecast period. Growth in medical business aspects and groundwork in emerging economies is fueling growth in medical tourism, driving the heart valve device market. The need for minimally invasive procedures to treat cardiac abnormalities has greatly increased. Current applications of automation in heart valve surgery, such as Transcatheter Aortic Valve Replacement (TAVR), have given way to a growing variety of similar surgeries. Judging by the increasing proportion of the aging population, the increase in life insurance policies is also expected to contribute to the growth of the heart valve market.
Heart Valve Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Innovations in Heart Valve Devices Offer Improved Clinical Outcome
Launching new products for minimally invasive procedures will likely drive the Europe heart valve devices market. Tissue valves have revolutionized the heart valve market. The next generation of heart valve surgery offers fewer delivery curves, more controlled placement, improved valve function, reduced valve regurgitation, increased durability, and reduced cost. Product innovation has boosted the growth prospects of heart valve device market players as it can treat a larger number of patients with superior clinical outcomes. Despite significant advances in recent years, structural interventional cardiology remains an emerging market with great potential.
Moreover, intelligent designs, new technologies, and biomaterials applications continue to push the boundaries of new product development, ensuring that these devices will be at the forefront of interventional product innovation for years to come. Design innovations are helping market players tap profitable growth opportunities in heart valve devices.
Thus, the growth of the Europe heart valve devices market is expected to propel due to the rise in innovations in heart valve devices.
- Rising number of various heart diseases
Heart attacks and strokes are usually acute events and are primarily caused by a blockage that blocks blood flow to the heart or brain. During the first year of the COVID-19 pandemic, heart disease and stroke deaths increased by 5.8% and 6.8%, respectively. However, the age-associated increases were 1.6% and 1.7% for heart disease and stroke, respectively. The most common cause is the build-up of fatty deposits in the lining of the blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a blood vessel in the brain. This trend suggests that the incidence of cardiovascular disease may increase dramatically due to population growth and aging.
Furthermore, High diabetes and blood pressure, high blood cholesterol, and smoking are key risk factors for heart disease. About half of people in the United States (47%) have at least one of these three risk factors. Other medical conditions and lifestyle choices can also put people at a higher risk for heart disease, including unhealthy diet, physical inactivity, and excessive alcohol use.
Moreover, the rising number of heart diseases is expected to act as a driver for the Europe heart valve devices market.
Opportunity
- Increasing Awareness of Prosthetic Devices
A prosthesis is a device designed to replace a missing body part or to improve the function of a body part. Prosthetic heart valves are increasingly used in cases of abnormalities of the natural valves that require intervention. Generally, they can be divided into mechanical heart valves, biological valves, and allogeneic grafts. The goal of artificial valves is to act hemodynamically like a natural valve with minimal side effects. Cardiovascular prostheses devices have been developed to replace damaged heart tissue. These medical devices are designed to mimic the function of normal cardiovascular organs. Artificial hearts allow heart surgeons to increase the treatment of heart blocks.
Moreover, the prevalence of prosthetic valves ranges from 0.2 per 1,000 in people years of age or younger to 5.3 in people years of age or younger.
Thus the increasing awareness about prosthetic devices acts as an opportunity for the market's growth.
Restraint/Challenge
- Expensive Production Cost of Equipment
The number of patients treated for aortic valve disease in the United States is growing quickly. Transcatheter aortic valve replacement (TAVR) replaces surgical aortic valve replacement (SAVR) and medical treatment (M.T.). The economic consequences of these trends are unknown. Therefore, the total cost of TAVR is higher than SAVR and much more expensive than M.T. alone. TAVR costs have decreased over time, while SAVR and M.T. costs have remained the same.
- In addition, the high surgical cost of TAVI is mainly due to the high cost of the production. However, due to the shorter hospital stay, the cost of non-surgical TAVI is lower compared to AVR. The cost of the TAVI implant kit alone (valve, balloon, sheath) is $32,500, while the surgical valve only costs about $5,000, just like in Switzerland, the TAVI implant set costs about 32,000 francs (around of $35,000), while the cost of a biosurgical prosthesis is about 3,000 Swiss francs (about US$3,300). Depending on comorbidities and complications, reimbursement in the United States is between $ 0,000 and $ 5,000, TAVI in Switzerland is about 72,000 francs ($78,000), and AVR is about 3,000 francs ($ 7,000), which means a financial loss for the hospital.
Thus, the rising production cost of equipment may hamper the market's growth.
Recent Developments
- In September 2023, Abbott released data from five late-stage presentations showing the benefits of its minimally invasive devices in treating people with various structural heart diseases. The data includes findings that support the value of MitraClip™. It is the world's first and leading transcatheter edge-to-edge repair (TEER) to treat leaky valves in people with mitral regurgitation (MR). New data on Abbott's structural heart therapies were presented at the Cardiovascular Research Foundation's 34th Annual Transcatheter Cardiovascular Therapy (TCT) Scientific Symposium in Boston. This has helped the company to increase its business position in the market.
- In September 2020, Boston Scientific Corporation announced that it had introduced a controlled launch of the ACURATE neo2™ aortic valve system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with multiple features to improve the clinical performance of the original ACURATE new platform. Compared to the previous generation, the ACURATE neo2 valve system has an expanded indication for patients with aortic stenosis. This has helped the company to gain its product portfolio.
Heart Valve Devices Market Scope
The heart valve devices market is segmented into product type, treatment, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
BY PRODUCT TYPE
- Mechanical Heart Valves
- Biological Heart Valve
- Transcatheter Valves
On the basis of product type, the heart valve devices market is segmented into mechanical heart valve, biological heart valve and transcatheter valve.
BY TREATMENT
- OPEN SURGERY
- MINIMALLY INVASIVE SURGERY
On the basis of treatment, the heart valve devices market is segmented into open surgery and minimal invasive surgery.
BY END USER
- HOSPITAL & CLINICS
- AMBULATORY SURGICAL CENTERS
- CARDIAC CENTERS
- RESEARCH CENTERS
- OTHERS
On the basis of end user, the heart valve devices market is segmented into hospitals & clinics, ambulatory surgical centers, cardiac centers, research centers and others.
BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- THIRD PARTY DISTRIBUTORS
On the basis of distribution channel, the heart valve devices market is segmented into direct tender and third party distributors.
Europe Heart Valve Devices Market Regional Analysis/Insights
The heart valve devices market is analyzed and market size information is provided product type, treatment, end user, and distribution channel.
The countries covered in this market report Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland and the rest of Europe.
Germany dominates Europe region due to the mass production of heart valve devices and increasing demand from emerging markets and expansion of healthcare industries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Heart Valve Devices Market Share Analysis
The heart valve devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the heart valve devices market.
Some of the key players operating in the heart valve devices market are Abbott, Boston Scientific Corporation or its affiliates, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve among others.
منهجية البحث: سوق أجهزة صمام القلب
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. بالإضافة إلى ذلك، يعد تحليل حصة السوق وتحليل الاتجاهات الرئيسية من عوامل النجاح الرئيسية في تقرير السوق. منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي مثلث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأساسي (خبير الصناعة). وبصرف النظر عن هذا، تتضمن نماذج البيانات شبكة وضع البائعين، وتحليل الخط الزمني للسوق، ونظرة عامة على السوق والدليل، وشبكة وضع الشركة، وتحليل حصة الشركة في السوق، ومعايير القياس، وأوروبا مقابل المنطقة، وتحليل حصة البائعين. يرجى طلب مكالمة محلل في حالة وجود استفسار آخر.
التخصيص متاح
تعتبر Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. نحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. يمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان) وبيانات نتائج التجارب السريرية ومراجعة الأدبيات وتحليل السوق المجدد وقاعدة المنتج. يمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. يمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. يمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (Factbook) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE HEART VALVE DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 EPIDEMIOLOGY
3.2 PESTEL ANALYSIS
3.3 PORTER'S FIVE FORCE
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME
4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES
4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY
4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES
4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT
4.3 OPPORTUNITIES
4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES
4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES
4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES
4.4 CHALLENGES
4.4.1 STRICT GOVERNMENT REGULATIONS
4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT
5 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVES
5.2.1 AORTIC VALVE
5.2.2 MITRAL VALVE
5.3 BIOLOGICAL HEART VALVES
5.3.1 AORTIC VALVE
5.3.2 MITRAL VALVE
5.3.3 PULMONARY VALVE
5.3.4 TRICUSPID VALVE
5.4 TRANSCATHETER VALVE
5.4.1 AORTIC VALVE
5.4.2 MITRAL VALVE
5.4.3 PULMONARY VALVE
6 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE SURGERY (MIS)
6.2.1 CARDIAC VALVE REPLACEMENT
6.2.2 CARDIAC VALVE REPAIR
6.3 OPEN SURGERY
6.3.1 CARDIAC VALVE REPLACEMENT
6.3.2 CARDIAC VALVE REPAIR
7 EUROPE HEART VALVE DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL & CLINICS
7.3 AMBULATORY SURGICAL CENTERS
7.4 CARDIAC CENTERS
7.5 RESEARCH CENTERS
7.6 OTHERS
8 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 THIRD PARTY DISTRIBUTORS
9 EUROPE HEART VALVE DEVICES MARKET, BY REGION
9.1 EUROPE
9.1.1 GERMANY
9.1.2 FRANCE
9.1.3 U.K.
9.1.4 ITALY
9.1.5 RUSSIA
9.1.6 SPAIN
9.1.7 TURKEY
9.1.8 NETHERLANDS
9.1.9 SWITZERLAND
9.1.10 BELGIUM
9.1.11 DENMARK
9.1.12 SWEDEN
9.1.13 POLAND
9.1.14 NORWAY
9.1.15 FINLAND
9.1.16 REST OF EUROPE
10 EUROPE HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 EDWARDS LIFESCIENCES CORPORATION
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ARTIVION, INC.
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 COLIBRI HEART VALVE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 FOLDAX, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 MERIL LIFE SCIENCES PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 NEOVASC
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 TTK
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 VENUS MEDTECH (HANGZHOU) INC.
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 XELTIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 9 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 11 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 13 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 EUROPE HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 20 EUROPE DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 28 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 29 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 30 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 31 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 32 GERMANY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 33 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 35 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 36 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 38 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 39 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 41 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 42 GERMANY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 43 GERMANY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 44 GERMANY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 45 GERMANY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 GERMANY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 47 FRANCE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 50 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 51 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 52 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 53 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 54 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 56 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 57 FRANCE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 58 FRANCE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 59 FRANCE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 60 FRANCE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 FRANCE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 U.K. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 65 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 66 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 68 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 69 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 71 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 72 U.K. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 73 U.K. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 74 U.K. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 75 U.K. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 U.K. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 77 ITALY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 80 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 81 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 83 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 84 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 86 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 87 ITALY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 88 ITALY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 89 ITALY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 90 ITALY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 ITALY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 94 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 95 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 96 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 98 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 99 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 101 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 102 RUSSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 103 RUSSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 104 RUSSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 105 RUSSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 RUSSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 107 SPAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 110 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 111 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 113 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 114 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 116 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 117 SPAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 118 SPAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 119 SPAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 120 SPAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 SPAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 122 TURKEY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 125 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 126 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 128 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 129 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 131 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 132 TURKEY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 133 TURKEY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 134 TURKEY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 135 TURKEY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 136 TURKEY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 137 NETHERLANDS HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 140 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 141 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 143 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 144 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 146 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 147 NETHERLANDS HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 148 NETHERLANDS MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 149 NETHERLANDS OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 150 NETHERLANDS HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 NETHERLANDS HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 152 SWITZERLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 155 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 156 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 158 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 159 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 161 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 162 SWITZERLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 163 SWITZERLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 164 SWITZERLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 165 SWITZERLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 166 SWITZERLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 167 BELGIUM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 168 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 170 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 171 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 173 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 174 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 176 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 177 BELGIUM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 178 BELGIUM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 179 BELGIUM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 180 BELGIUM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 BELGIUM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 182 DENMARK HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 185 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 186 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 188 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 189 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 191 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 192 DENMARK HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 193 DENMARK MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 194 DENMARK OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 195 DENMARK HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 196 DENMARK HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 197 SWEDEN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 200 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 201 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 203 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 204 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 206 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 207 SWEDEN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 208 SWEDEN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 209 SWEDEN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 210 SWEDEN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 211 SWEDEN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 POLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 215 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 216 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 218 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 219 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 221 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 222 POLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 223 POLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 224 POLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 225 POLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 POLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 227 NORWAY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 228 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 230 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 231 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 233 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 234 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 236 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 237 NORWAY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 238 NORWAY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 239 NORWAY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 240 NORWAY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 241 NORWAY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 242 FINLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 244 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 245 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 246 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 248 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 249 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 250 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 251 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 252 FINLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 253 FINLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 254 FINLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 255 FINLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 FINLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 257 REST OF EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 EUROPE HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE HEART VALVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE HEART VALVE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE HEART VALVE DEVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 11 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE EUROPE HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD
FIGURE 12 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HEART VALVE DEVICES MARKET IN 2023 & 2030
FIGURE 13 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA
FIGURE 14 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE
FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC
FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE HEART VALVE DEVICES MARKET
FIGURE 18 EUROPE HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022
FIGURE 19 EUROPE HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 EUROPE HEART VALVE DEVICES MARKET : BY TREATMENT, 2022
FIGURE 23 EUROPE HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)
FIGURE 25 EUROPE HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE
FIGURE 26 EUROPE HEART VALVE DEVICES MARKET : BY END USER, 2022
FIGURE 27 EUROPE HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 39 EUROPE HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
